Evidence map›Paper›PMID 41225968›Full record

ReviewDiagnostics (Basel, Switzerland)2025

MOC31 for the Diagnosis of Metastatic Carcinoma and Mesothelial Lesions in Effusion Fluid-A Systematic Review and Meta-Analysis.

Alex H Lin, Matthew Hsu, Joanna K M Ng, Sahar J Farahani, Renald Meçani, Jana Nano, Joshua J X Li, Philippe Vielh, Taulant Muka

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alex H LinDepartment of Pathology, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
Matthew HsuDepartment of Pathology, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
Joanna K M NgDepartment of Pathology, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
Sahar J FarahaniDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Renald MeçaniDepartment of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.
Jana NanoDepartment of Radiation Oncology, TUM School of Medicine and Health, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
Joshua J X LiDepartment of Pathology, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
Philippe VielhDepartment of Pathology, Medipath and American Hospital of Paris, 92200 Paris, France.ORCID 0000-0003-2574-3241
Taulant MukaEpistudia, 3008 Bern, Switzerland.ORCID 0000-0003-3235-3073

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunocytochemistrymesotheliomameta-analysismetastatic carcinomaMOC31serous effusion

Identifiers

PMID41225968
PMCPMC12608982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.